tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ziyi Chen, 2 are a HOLD (16.67%), 10 are a BUY (83.33%).
Analyst Ziyi Chen, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 15% that have a potential upside of 11.66% achieved within 65 days.
Ziyi Chen’s has documented 23 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 17-Mar-2024.
Analyst best performing recommendations are on ZLAB (ZAI LAB LTD).
The best stock recommendation documented was for ZLAB (ZAI LAB LTD) at 4/27/2020. The price target of $77.23 was fulfilled within 53 days with a profit of $12.68 (19.64%) receiving and performance score of 3.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2019
$260
$75.29 (40.76%)
$260
1 years 10 months 11 days ago
(17-Dec-2024)
7/13 (53.85%)
$80.94 (45.20%)
148
Buy Since 03-Dec-2024
$300
$115.29 (62.42%)
1 years 10 months 25 days ago
(03-Dec-2024)
0/1 (0%)
$93.99 (45.62%)
Hold Since 29-Jun-2023
$207
$22.29 (12.07%)
$161
1 years 10 months 29 days ago
(29-Nov-2024)
3/4 (75%)
$-8 (-3.72%)
18
Buy Since 20-Aug-2024
$235
$50.29 (27.23%)
$200
2 years 6 days ago
(22-Oct-2024)
4/5 (80%)
$14.37 (6.51%)
130
Buy Since 14-May-2019
$307
2 years 2 months 2 days ago
(26-Aug-2024)
12/24 (50%)
$113.18 (58.39%)
58
What Year was the first public recommendation made by Ziyi Chen?
